Eureka
I have found it
Kari's Law Reporting Act
The bill increases FCC transparency and could improve 911 access for vulnerable callers, but it creates modest taxpayer costs and may raise compliance burdens for manufacturers and vendors if stricter enforcement or new rules follow.
Emergency Reporting Act
The bill improves transparency and oversight of communications outages—helping emergency response and bringing stakeholder input—while imposing agency workload, leaving some data confidential, and potentially increasing compliance costs for providers.
Reversionary Interest Conveyance Act
The bill clarifies and enables sale of federal reversionary interests to current recorded owners and protects railroad property rights—giving local owners and the railroad clearer title and operational certainty—while raising acquisition costs, restricting who may obtain lands, and reducing some federal control over future public land uses.
FUTURE Networks Act
The bill concentrates federal coordination to speed and standardize 6G rollout and risk mitigation, but does so with exclusionary authorities and tight timelines that may limit participation, transparency, and depth of analysis while creating modest administrative costs.
Digital Opportunity Foundation Act of 2026
The bill creates a Foundation to expand broadband access, digital training, and local grantmaking—potentially improving connectivity and skills for underserved communities—while concentrating significant operational authority outside usual federal safeguards and creating risks of ongoing federal costs and conflicts of interest.
Ensuring Excellence in Mental Health Act
The bill seeks to expand and stabilize access to community behavioral health care (Medicaid/Medicare coverage, predictable payments, grants, and clinician protections), improving care availability and affordability but increasing federal/state costs, creating implementation and compliance burdens, and narrowing some individual legal remedies for patients.
Drug Origin Transparency Act of 2026
The bill gives regulators stronger visibility into drug supply chains to speed recalls and reduce shortages—benefiting patients and health systems—but imposes new reporting and disclosure requirements that raise costs, proprietary risks, and compliance burdens that will fall hardest on smaller suppliers and could raise prices or reduce market diversity.
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.
The bill shifts Part D formularies toward lower-cost generics and biosimilars to lower beneficiary costs and reduce program spending, but does so at the risk of higher plan administrative costs, uncertain manufacturer pricing responses, and potential disruption for some patients.
Whale CHARTS Act of 2026
The bill funds mapping, near-real-time monitoring, and competitive grants to reduce whale strikes and spur innovation, but it increases federal spending and administrative constraints that may limit participation and add workload for agencies.
Senior Savings Protection Act
The bill directs modest, targeted federal funding to expand outreach, coordination, and local aging/disability supports to help seniors and people with disabilities access benefits, at the cost of recurring federal spending and with uncertain real-world impact if local capacity is limited.